Company Name, Ticker, Customers, else..

Palvella Therapeutics Inc (NASDAQ: PVLA)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Palvella Therapeutics Inc 's

Name: Palvella Therapeutics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PVLA Sales vs. its Competitors Q2 2026

Comparing the current results to its competitors, Palvella Therapeutics Inc reported Revenue increase in the 2 quarter 2026 by 0 % year on year.
The revenue growth was below Palvella Therapeutics Inc 's competitors' average revenue growth of 3.11 %, achieved in the same quarter.

• List of PVLA Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Palvella Therapeutics Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< PVLA Stock Performance Comparisons

<< See the full list of PVLA competitors

*Market share is calculated based on total revenue.

PVLA's Stock Performance relative to its Competitors

Publicly Traded Peers of Palvella Therapeutics Inc

Iovance Biotherapeutics inc
Share Performance

+224.21%

This Year

Iovance Biotherapeutics inc

Profile

Iovance Biotherapeutics Inc operates on a business model centered around developing and commercializing novel cancer immunotherapy treatments. The company focuses on utilizing its proprietary Tumor Infiltrating Lymphocyte (TIL) therapy, which involves collecting and expanding a patient's own immune cells to target and kill cancer cells. Iovance primarily seeks to advance its TIL therapy candidates through clinical trials and collaborations while aiming to provide effective and personalized treatment options for cancer patients.

More about Iovance Biotherapeutics inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 3,419.235 mill.	$ 285.608 mill.	$ -353.860 mill.

Medicure Inc
Share Performance

0.00%

Over The Past 5 Days

Medicure Inc

Profile

Medicure Inc operates as a pharmaceutical company with a business model that focuses on the research, development, and commercialization of innovative cardiovascular and other specialty pharmaceuticals. They aim to address unmet medical needs, improve patient outcomes, and deliver value to healthcare providers and consumers.

More about Medicure Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ 22.103 mill.	$ -5.436 mill.

Moderna Inc
Share Performance

+354.76%

This Year

Moderna Inc

Profile

Moderna Inc's business model revolves around the development and commercialization of mRNA-based therapeutics and vaccines. They focus on using messenger RNA (mRNA) technology to create drugs that can help prevent and treat various diseases.

More about Moderna Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 55,855.320 mill.	$ 2,228.000 mill.	$ -3,151.000 mill.

Mersana Therapeutics inc
Share Performance

+0.21%

This Year

Mersana Therapeutics inc

Profile

Mersana Therapeutics Inc's business model focuses on developing and commercializing novel antibody-drug conjugates (ADCs) for the treatment of cancer.

More about Mersana Therapeutics inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 145.286 mill.	$ 33.180 mill.	$ -70.081 mill.

Novabridge Biosciences
Share Performance

-2.67%

This Quarter

Novabridge Biosciences

Profile

The company develops drug candidates and conducts related research and development activities in China.

More about Novabridge Biosciences's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 174.292 mill.	$ - mill.	$ -88.340 mill.

82 more competitors available

Sources: Palvella Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 4:59 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Palvella Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.